The Impact of Frequent and Unrecognized Hypoglycemia on Mortality in the ACCORD Study
Authors:
- Elizabeth R. SeaquistESElizabeth R. Seaquist
- Kevin PetersonKPKevin Peterson
- Peter SeniorPSPeter Senior
- for the ACCORD InvestigatorsFIfor the ACCORD Investigators
Open Access
- 16 January 2012
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 35 (2) , 409-414
Abstract
OBJECTIVE: The aim of this study was to examine the relationship between frequent and unrecognized hypoglycemia and mortality in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study cohort. RESEARCH DESIGN AND METHODS: A total of 10,096 ACCORD study participants with follow-up for both hypoglycemia and mortality were included. Hazard ratios (95% CIs) relating the risk of death to the updated annualized number of hypoglycemic episodes and the updated annualized number of intervals with unrecognized hypoglycemia were obtained using Cox proportional hazards regression models, allowing for these hypoglycemia variables as time-dependent covariates and controlling for the baseline covariates. RESULTS: Participants in the intensive group reported a mean of 1.06 hypoglycemic episodes (self-monitored blood glucose <70 mg/dL or <3.9 mmol/L) in the 7 days preceding their regular 4-month visit, whereas participants in the standard group reported an average of 0.29 episodes. Unrecognized hypoglycemia was reported, on average, at 5.8% of the intensive group 4-month visits and 2.6% of the standard group visits. Hazard ratios for mortality in models including frequency of hypoglycemic episodes were 0.93 (95% CI 0.9–0.97; P < 0.001) for participants in the intensive group and 0.98 (0.91–1.06; P = 0.615) for participants in the standard group. The hazard ratios for mortality in models, including unrecognized hypoglycemia, were not statistically significant for either group. CONCLUSIONS: Recognized and unrecognized hypoglycemia was more common in the intensive group than in the standard group. In the intensive group of the ACCORD study, a small but statistically significant inverse relationship of uncertain clinical importance was identified between the number of hypoglycemic episodes and the risk of death among participants.Keywords
This publication has 9 references indexed in Scilit:
- Cognitive Impairment: An Independent Predictor of Excess MortalityAnnals of Internal Medicine, 2011
- Severe Hypoglycemia and Risks of Vascular Events and DeathNew England Journal of Medicine, 2010
- Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD TrialDiabetes Care, 2010
- The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD studyBMJ, 2010
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Severe Hypoglycemia Monitoring and Risk Management Procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) TrialThe American Journal of Cardiology, 2007
- Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes.Diabetes, 1998
- Resistance to Neuroglycopenia: An Adaptative Response during Intensive Insulin Treatment of DiabetesThe Journal of Clinical Endocrinology & Metabolism, 1997
- Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDMDiabetes, 1994